Radiation therapy in stage II ovarian carcinoma. The influence of histologic grade
โ Scribed by Peter M. Mauch; Robert L. Ehrmann; C. Thomas Griffiths; Abraham Marck; Robert C. Knapp; Martin B. Levene
- Publisher
- John Wiley and Sons
- Year
- 1980
- Tongue
- English
- Weight
- 844 KB
- Volume
- 45
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Background. Prior reports suggested that measuring c-erbB-2 activation in ovarian carcinomas might be valuable in predicting prognosis. The authors attempted to confirm these studies while specifically excluding tumors of low malignant potential. Methods. The clinical and pathologic significance of
Sixty-three eligible patients with Ann Arbor clinical Stage I1 or IIE aggressive histologic type non-Hodgkin's lymphomas received combination chemotherapy (cyclophosphamide, doxorubicin, vincristine, and prednisone (COPAJ) as the primary treatment technique. Moderate-dose radiation therapy (2500 to